ZELENINA DROPS

INSTRUCTION FOR MEDICAL USE OF THE MEDICINAL PRODUCT ZELENINA DROPS

Composition:

Active ingredients: 1 ml of the preparation contains: belladonna tincture (Belladonnaefoliumautherba) (1:10) (extractant – 40% ethanol) – 0.2 ml; lily-of-the-valley tincture (Convallariaeherba) (1:10) (extractant – 70% ethanol) – 0.4 ml; valerian tincture (Valerianaerhizomacumradicibus) (1:5) (extractant – 70% ethanol) – 0.4 ml; menthol – 0.008 g.

Pharmaceutical form. Oral drops.

Main physicochemical properties: greenish or yellow-brown liquid with a characteristic odour. Sediment may form during storage.

Pharmacotherapeutic group. Various combined cardiovascular preparations.

ATC code C01EX.

Pharmacological properties.

Pharmacodynamics. A combined herbal preparation. The components of the tinctures reduce excitability of the central nervous system, exert a spasmolytic effect, have a slight cardiotonic effect, and increase heart rate.

Valeric acid provides a sedative effect on the central nervous system. Belladonna tincture blocks M-cholinoreceptors of smooth muscles of internal organs, thus producing a spasmolytic effect. Menthol, by stimulating the oral mucosa, reflexively dilates coronary vessels.

Pharmacokinetics. Not studied.

Clinical characteristics.

Indications.

Neurocirculatory dystonia, bradycardia.

Contraindications.

Glaucoma, organic lesions of the heart and blood vessels, prostatic hypertrophy, individual intolerance to the drug.

Interaction with other medicinal products and other forms of interactions.

The drug enhances the effect of sedatives, hypnotics, neuroleptics, and tranquilizers on the central nervous system, as well as that of cardiotonics and analgesics. It reduces the efficacy of antiarrhythmic agents used in the treatment of tachycardia.

Special precautions for use.

"Zelena Kapli" should be administered with caution to elderly individuals and children aged 12 years and older due to the presence of belladonna tincture in the formulation.

Use during pregnancy or breastfeeding.

Do not use the drug during pregnancy or breastfeeding.

Ability to influence reaction rate while driving or operating machinery.

During treatment with this medicinal product, driving vehicles or operating machinery should be avoided.

Method of Administration and Dosage.

For oral use in adults: 20–25 drops 2–3 times daily, diluted in a small amount of water. For children aged 12 years and older: 1 drop per year of life, 2–3 times daily. The duration of treatment is determined by a physician.

Children.

Do not use in children under 12 years of age.

Overdose.

Symptoms may include palpitations, dry mouth, accommodation disturbances, dilated pupils, headache, dizziness, general weakness, nausea, and tachycardia. In case of overdose symptoms, discontinue the drug immediately and consult a physician for symptomatic therapy.

Side effects.

Neurological disorders: psychomotor agitation, drowsiness, depression, decreased mental and physical performance, emotional blunting, headache, dizziness, visual disturbances.

Cardiac disorders: tachycardia.

Gastrointestinal disorders: dry mouth, thirst, nausea, vomiting, diarrhea, constipation.

Musculoskeletal and connective tissue disorders: muscle weakness.

Allergic reactions, including skin redness, rash, itching, swelling.

General disorders: increased body temperature.

Shelf life. 3 years.

Storage conditions.

Store in a place protected from light and inaccessible to children, at a temperature not exceeding 25°C.

Packaging.

25 ml in dropper bottles, in a carton or without a cart游戏副本 Category of supply. Over-the-counter.

Manufacturer/Applicant.

LLC "Ternopharm".

Address of manufacturer or applicant and location of its operations.

LLC "Ternopharm".

4 Hrabova St., Ternopil, 46010, Ukraine.